https://www.selleckchem.com/pr....oducts/cilofexor-gs-
Multiple sclerosis (MS) is a chronic illness involving the central nervous system (CNS) that is characterised by inflammation, demyelination, and degenerative changes. Dalfampridine is one of the available treatments for MS symptoms and comorbidities. This meta-analysis aimed to assess the safety and benefits of dalfampridine versus placebo in MS by summarising data deriving from previously published clinical randomised controlled studies (RCTs). A total of 9 RCTs were included in this meta-analysis, involving 1691 participant
Like
Comment
Share
